Deal History

Achelous Partners acted as M&A advisor to A4P Consulting, a UK-based scientific consultancy for clinical trials, on its sale to LabConnect, a global central laboratory services provider.

Achelous Partners served as M&A advisor to Diamond Pharma Services, a pharmaceutical quality and compliance consulting provider, on its sale to ProPharma Group, a portfolio company of Odyssey Investment Partners.

Achelous Partners acted as exclusive financial advisor to Plasma Services Group, a New Jersey-based supplier of rare biological materials and samples for IVD and life science industries founded in 2004.

Achelous Partners acted as exclusive financial advisor to Bio X Cell, a leading producer of monoclonal antibodies for in vivo and in vitro pre-clinical research applications with 400+ antibody portfolio and 1,500+ customers.

Achelous Partners served as exclusive M&A advisor to Expression Systems, a cell culture media and biological buffers manufacturer, on its sale to ANGUS Chemical Company, a portfolio company of Ardian and Golden Gate Capital.

Achelous Partners served as advisor to Cergentis, a genomics-focused biotechnology company, on its sale to Solvias to bolster biologics and cell & gene therapy capabilities.

Achelous Partners acted as financial advisor to BioControl Systems, a food safety testing products company, on its sale to Merck/MilliporeSigma.

Achelous Partners acted as exclusive financial advisor to Purna Pharmaceuticals, a Belgian CDMO providing development and manufacturing services for liquid and semi-solid dosage forms, on its sale to Ampersand Capital Partners.

Achelous Partners advised Curia on the sale of its US-based CDMO site specializing in early-phase pharmaceutical development and manufacturing to Siegfried.

Achelous Partners advised Symbio, a US-based consulting and testing firm serving the life sciences industry, on its sale to Archimed, a global private equity healthcare specialist.

Achelous Partners advised Proinnovera, a Germany-based clinical research consulting firm, on its sale to Archimed, which simultaneously merged Symbio and Proinnovera.

Achelous Partners provided investment banking and advisory services to Clinical Outcomes Solutions, a global leader in clinical outcomes assessment research services, on its sale to Validant.

Achelous Partners advised MLM Medical Labs, a German central laboratory for clinical trials, on its sale to Great Point Partners, a US-based life science focused private equity fund.

Achelous Partners provided investment banking and advisory services to Six Degrees Worldwide, a leader in medical communications serving biopharmaceutical clients in over 40 countries, on its sale to Reverba.

Achelous Partners served as exclusive M&A advisor to BresMed Health Solutions, a health economics and outcomes research consultancy with 150+ staff across UK, Ireland, Netherlands, US, and India.